Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean J Zhao

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Oncotarget|July 9, 2016
CDK4/6 inhibition: the late harvest cycle beginsShom Goel, Jean J Zhao
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2009
Estrogen receptor-negative breast cancer: new insights into subclassification and targetingJean J Zhao, Daniel P Silver
Science'S STKE : Signal Transduction Knowledge Environment|December 14, 2006
PI3 kinases in cancer: from oncogene artifact to leading cancer targetJean J Zhao, Thomas M Roberts
Cancer Research|December 16, 2021
How Compensatory Mechanisms and Adaptive Rewiring Have Shaped Our Understanding of Therapeutic Resistance in CancerJohann S Bergholz, Jean J Zhao
Cell Cycle (Georgetown, Tex.)|October 18, 2013
The gene dosage of class Ia PI3K dictates the development of PTEN hamartoma tumor syndromeQi Wang, Ellen Weisberg, Jean J Zhao
Nature Reviews. Cancer|December 24, 2014
PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targetingLauren M Thorpe, Haluk Yuzugullu, Jean J Zhao
Current Opinion in Cell Biology|February 10, 2009
Should individual PI3 kinase isoforms be targeted in cancer?Shidong Jia, Thomas M Roberts, Jean J Zhao
Nature Reviews. Cancer|March 19, 2022
Targeting CDK4 and CDK6 in cancerShom Goel, Johann S Bergholz, Jean J Zhao
Trends in Pharmacological Sciences|August 2, 2025
Beyond G protein and arrestin: GRK2-biased β₂AR signalingRen-Lei Ji, Zhe Wang, Jean J Zhao
Trends in Molecular Medicine|July 10, 2004
Functional genetics and experimental models of human cancerJean J Zhao, Thomas M Roberts, William C Hahn
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Oncotarget|July 9, 2016
CDK4/6 inhibition: the late harvest cycle beginsShom Goel, Jean J Zhao
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2009
Estrogen receptor-negative breast cancer: new insights into subclassification and targetingJean J Zhao, Daniel P Silver
Science'S STKE : Signal Transduction Knowledge Environment|December 14, 2006
PI3 kinases in cancer: from oncogene artifact to leading cancer targetJean J Zhao, Thomas M Roberts
Cancer Research|December 16, 2021
How Compensatory Mechanisms and Adaptive Rewiring Have Shaped Our Understanding of Therapeutic Resistance in CancerJohann S Bergholz, Jean J Zhao
Cell Cycle (Georgetown, Tex.)|October 18, 2013
The gene dosage of class Ia PI3K dictates the development of PTEN hamartoma tumor syndromeQi Wang, Ellen Weisberg, Jean J Zhao
Nature Reviews. Cancer|December 24, 2014
PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targetingLauren M Thorpe, Haluk Yuzugullu, Jean J Zhao
Current Opinion in Cell Biology|February 10, 2009
Should individual PI3 kinase isoforms be targeted in cancer?Shidong Jia, Thomas M Roberts, Jean J Zhao
Nature Reviews. Cancer|March 19, 2022
Targeting CDK4 and CDK6 in cancerShom Goel, Johann S Bergholz, Jean J Zhao
Trends in Pharmacological Sciences|August 2, 2025
Beyond G protein and arrestin: GRK2-biased β₂AR signalingRen-Lei Ji, Zhe Wang, Jean J Zhao
Trends in Molecular Medicine|July 10, 2004
Functional genetics and experimental models of human cancerJean J Zhao, Thomas M Roberts, William C Hahn
Pageof 13